Author | Eric Vallières, MD

September 14, 2009

Despite all of its theoretical advantages, the use of induction chemotherapy is still considered experimental in the management of early-stage resectable NSCLC.

July 01, 1999

Grondin and Sugarbaker provide an excellent, thorough review of malignant pleural mesotheliomas. Nearly 3,000 new mesotheliomas will be diagnosed in the United States this year. On the positive side, epidemiologists estimate that workplace